End-Stage Liver Diseases
2
0
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Infusion Of Umbilical Cordmesenchymal Stem Cells Through Peripheral Veins
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 2 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Human Umbilical Cord-mesenchymal Stem Cells Via Different Transplantation Routes in ESLD
Effect of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD
Research Network
Common Treatments
- Infusion Of Umbilical Cordmesenchymal Stem Cells Through Peripheral Veins1
- Umbilical Cordmesenchymal Stem Cells1
- Infusion Of Umbilical Cordmesenchymal Stem Cells Through Hepatic Artery1
Active Sponsors
- General Hospital of Shenyang Military Region2
Top Investigators
The General Hospital of Northern Theater Command Study Director
The General Hospital of Northern Theater Command Study Director
The General Hospital of Northern Theater Command